麦角酸二乙酰胺（LSD）与硫利达嗪治疗慢性精神分裂症的试验 - Suppr | 超能文献

Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.

作者信息

Shirvaikar R V, Kelkar Y W

出版信息

Neurol India. 1966 Apr-Jun;14(2):97-101.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.麦角酸二乙酰胺（LSD）与硫利达嗪治疗慢性精神分裂症的试验

Neurol India. 1966 Apr-Jun;14(2):97-101.

2

The use of LSD and ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach).

Dis Nerv Syst. 1969 Feb;30(2):Suppl:93-103.

3

Preliminary method for study of LSD with children.

Int J Neuropsychiatry. 1965 Dec;1(6):552-5.

4

A controlled study of the effects of gamfexine in phenothiazine-treated patients.一项关于甘非西酯对接受吩噻嗪治疗患者影响的对照研究。

Curr Ther Res Clin Exp. 1970 Apr;12(4):230-3.

5

[The influence of iprazid and reserpine on the effect of lysergic acid diethylamide].[异烟酰异丙肼和利血平对麦角酸二乙酰胺效果的影响]

Zh Nevropatol Psikhiatr Im S S Korsakova. 1966;66(10):1571-4.

6

Drug therapy.药物治疗。

Prog Neurol Psychiatry. 1967;22:509-28. doi: 10.1016/b978-1-4831-9662-6.50035-4.

7

Long-term treatment of chronic schizophrenia. A preliminary report.

Int J Psychiatry. 1967 Aug;4(2):116-28.

8

Steroids and moods: correlations in schizophrenics and subjects treated with lysergic acid diethylamide (LSD), mescaline, tetrahydrocannabinol, and synhexyl.

J Clin Pharmacol J New Drugs. 1969 Jan-Feb;9(1):24-9.

9

Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state.三甲氧苯乙胺和麦角酸二乙酰胺：药物诱发状态的治疗意义。

Dis Nerv Syst. 1969 Feb;30(2):Suppl:23-7.

10

Pimozide in chronic schizophrenic patients.匹莫齐特用于慢性精神分裂症患者。

J Clin Pharmacol New Drugs. 1971 Jul-Aug;11(4):304-9.

引用本文的文献

1

Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration.裸盖菇素-N-甲基-D-天冬氨酸受体调节剂给药的协同行为和神经可塑性效应。

Transl Psychiatry. 2025 Jun 13;15(1):200. doi: 10.1038/s41398-025-03428-x.

2

Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.重新审视致幻剂诱发精神病的证据：综述概述、系统评价及人类研究的荟萃分析

Mol Psychiatry. 2025 Mar;30(3):1223-1255. doi: 10.1038/s41380-024-02800-5. Epub 2024 Nov 27.